abstract |
The invention relates to dihydroboswellic acids and the physiologically tolerable salts and derivatives thereof, the physiologically tolerable salts of said derivatives and hydrogenated extracts of boswellia. The invention also relates to a method for the production of the same and the use of dihydroboswellic acids, physiologically tolerable salts, and derivatives thereof, the physiologically tolerable salts of said derivatives or hydrogenated extracts of boswellia for prophylactic and/or therapeutic treatment of undesired physical or mental conditions in humans or animals. |